top of page

Ceribell, the developer of a novel headband designed to speed seizure detection in hospitals, goes public on Nasdaq.

Ceribell, the developer of the first AI-powered point-of-care EEG diagnostic system aimed to revolutionize seizure management in acute care, goes public on Nasdaq under the ticker CBLL. Ceribell System, is a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated AI-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Camford Capital has been a proud supporter of the company since 2015. More about the company's announcement is here.


Ceribell team in front of Nasdaq during the company's listing date on the exchange

bottom of page